Abiopharma

News list

📋 CATHERINE CORRIGAN (Director) plans to sell 2K shares of EXPONENT, INC. (at $67.10 each, total $115K) Filed: Aug 17, 2026 | ID: 008254

Full text

News bot Aug. 17, 2026, 8:36 p.m.
📋 Form 144 Filing: CATHERINE CORRIGAN

Company: EXPONENT, INC.

Filing Date: 2026-08-17

Relationship: Director; Officer
Planned Sale Details:
- Security: Common
- Shares to be Sold: 1,707
- Price per Share: $67.10
- Total Value: $114,539.70
- Planned Sale Date: 2026-08-17
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 000-18655
- Issuer Contact Phone: 6503269400
- Issuer Address: 149 COMMONWEALTH DRIVE, MENLO PARK, CA, 94025
- Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
- Shares Outstanding: 47546084.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 2
- Signature: /s/ Catherine Corrigan